SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : India Coffee House

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mohan Marette who wrote (8389)10/13/1999 10:21:00 PM
From: Mohan Marette  Read Replies (1) of 12475
 
StockWatch: Alembic Ltd re-rated

Alembic Ltd
alembic-india.com
alembic-india.com

10/14/99

ALEMBIC Ltd has been hitting the upper circuit on the BSE for the past four days. The stock price, which was frozen at Rs 459 on Tuesday, opened at an encouraging Rs 496 on Wednesday, despite weak market sentiment. After touching an intra-day low of Rs 490, the stock price closed at Rs 496, up Rs 37 (above eight per cent).

The Alembic scrip has been attracting attention, especially after its share value was split from Rs 100 to Rs 10. The scrip was unavailable for trading between July 23 and August 30, and resumed trading at Rs 284 (face value Rs 10) on the BSE on August 31. Since then, the stock price has appreciated by a sharp Rs 212 (75 per cent).

The stock is getting re-rated as most other pharma stocks are quoting at P/Es varying from 25 times to 50 times. While market euphoria is on account of high expectations on the quarterly performance, the past performance has also been a driving force behind the spurt in the stock price, say dealers. (FT)

The company has posted a 250 per cent jump in net profit to Rs 11 crore on sales of Rs 191 crore during the six-month period ended June 30, '99.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext